SCHEMBL25399661

SCHEMBL25399661

COC(=O)C1(Cc2ccccc2)CC(CNC(=O)c2ccnnc2)=NO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ HPGDS O60760 5/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ HPGD P15428 1/20 0.34
▸ ROCK2 O75116 1/20 0.33
▸ RPS6KA5 O75582 1/20 0.33
▸ MAP4K4 O95819 1/20 0.33
▸ PRKCG P05129 1/20 0.33
▸ PRKACA P17612 1/20 0.33
▸ RPS6KB1 P23443 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ GSK3A P49840 1/20 0.33
▸ GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25397863 0.89 CHRM1 (0.41) LMNASMN1; SMN2L3MBTL1ALDH1A1HPGD
SCHEMBL25397201 0.85 SMN1; SMN2 (0.47) LMNASMN1; SMN2HTTHPGDROCK2
SCHEMBL25397713 0.84 NPC1 (0.49) SMN1; SMN2HTTL3MBTL1ALDH1A1NPSR1
SCHEMBL25401868 0.84 TMEM97 (0.40) LMNASMN1; SMN2HTTL3MBTL1ALDH1A1
SCHEMBL25400330 0.84 SMN1; SMN2 (0.41) LMNASMN1; SMN2HTTL3MBTL1USP2
SCHEMBL25403031 0.84 LMNA (0.47) LMNASMN1; SMN2HPGD
SCHEMBL25401149 0.83 NPC1 (0.47) SMN1; SMN2HTTL3MBTL1ALDH1A1HPGD
SCHEMBL25398162 0.83 AURKA (0.46) SMN1; SMN2ALDH1A1HPGDROCK2MAP4K4
SCHEMBL29847004 0.83 EPHX2 (0.41) LMNAHPGDSL3MBTL1CA2
SCHEMBL25398251 0.82 POLB (0.48) LMNASMN1; SMN2HTTALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 — — US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 — — US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 LMNA 151/4885SMN1; SMN2 777/4885HTT 1191/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 LMNA 1548/4885SMN1; SMN2 213/4885HTT 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback